|Bid||78.18 x 1800|
|Ask||78.64 x 1300|
|Day's Range||76.87 - 81.16|
|52 Week Range||72.51 - 221.00|
|Beta (5Y Monthly)||1.59|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 23, 2022 - Feb. 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||118.31|
Yahoo Finance Live discusses U.S. plant-based meat sales declining as low as 0.6% in 2021.
Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. Shares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the S&P 500 has soared by more than 5%. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine.
Investors need to pay close attention to Beyond Meat (BYND) stock based on the movements in the options market lately.